Moderately to Severely Acute Ulcerative Colitis: Efficacy and Safety of Adalimumab
12/30/2008

California, Colorado, Connecticut, Florida, Georgia, Illinois, Indiana, Kansas, Maryland, Massachusetts, Michigan, Minnesota, Missouri, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Utah, Washington, Wisconsin; Argentina, Australia, Austria, Belgium, Canada, Czech Republic, Denmark, France, Germany, Hungary, New Zealand, Norway, Poland, Portugal, Spain, Sweden, Switzerland. clinicaltrials.gov

Related Summaries